[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f1oavvbftqvwb7":3},{"data":4,"error":10},{"id":5,"documentId":6,"heading":7,"body":8,"slug":9,"name":9,"name_ar":10,"proprietary_name":10,"non_proprietary_name":10,"is_proprietary":10,"active_ingredient":10,"administration_route":10,"available_strength":10,"dosage_form":10,"dose_schedule":10,"drug_unit":10,"is_available_generically":10,"mechanism_of_action":10,"overdosage":10,"warning":10,"species":11,"citations":12,"dose_schedules":58,"available_strengths":154,"label_statements":231,"drug_classes":282,"specialties":283,"medical_conditions":284,"animal_species":291},2294,"n510gy2n47k13lrvjlwhlasf","أوكسيتوسين","الأوكسيتوسين (oxytocin) ببتيد عصبي من تسعة أحماض أمينية يعمل هرموناً عصبياً وناقلاً عصبياً في آن واحد، وتصفه مراجعة منشورة في مجلة Animals عام 2023 بأنه هرمون أساسي للولادة وللصفات الأمومية لدى الحيوانات. يذكر دليل MSD البيطري أن الأوكسيتوسين، إلى جانب استعماله لإدرار الحليب ولانقباض الرحم حول الولادة، يُستعمل علاجاً مساعداً في [التهاب الضرع](\u002Fmedical-conditions\u002Fmastitis) وانعدام الحليب في أنواع حيوانية متعددة.\n\n## ما هو الدواء وإلى أي صنف ينتمي\n\nيذكر ملخص خصائص المستحضر (SPC) لمستحضر حقن لدى مديرية الأدوية البيطرية في المملكة المتحدة (VMD) أن مادته الفعالة أوكسيتوسين مصنّع، وهو ببتيد مطابق لنظيره الموجود في الطبيعة.\n\n## آلية العمل\n\nيرى ملخص خصائص المستحضر (SPC) لدى مديرية الأدوية البيطرية في المملكة المتحدة (VMD) في الأوكسيتوسين هرموناً يستثير نزول الحليب، فضلاً عن تعزيزه قدرة عضلة الرحم على الانقباض، وهو تعزيز يبرز أثناء الولادة وبعدها. يذكر دليل MSD البيطري، في فصل إدارة تناسل الخنازير، أن الأوكسيتوسين يُفرَز من الفص الخلفي للغدة النخامية، وأن إفراز الأوكسيتوسين يسبب انقباضات الرحم وبدء المخاض. يذكر دليل MSD البيطري في فصل إدارة تناسل الخنازير أيضاً أن تنبيه الظهر والخاصرة والبطن يمكن أن يحرّض إفراز الأوكسيتوسين وانقباضات رحمية تسحب السائل المنوي إلى داخل الرحم. تنسب مراجعة مجلة Animals لعام 2023 إلى مستويات الأوكسيتوسين الداخلي حول الولادة التحكم في انقباض عضل الرحم وفي إنتاج البروستاغلاندين، وتربط الأوكسيتوسين كذلك بدعم الإرضاع. يذكر ملخص خصائص المستحضر (SPC) لدى مديرية الأدوية البيطرية في المملكة المتحدة (VMD) أن الأوكسيتوسين يُزال من الجسم بسرعة كبيرة، وأن متوسط عمر النصف للتوزيع يبلغ نحو دقيقتين وعمر النصف للإطراح نحو 12 دقيقة. يذكر ملخص خصائص مستحضر لدى مديرية الأدوية البيطرية في المملكة المتحدة (VMD) أن الأدرينالين بمستوياته الفسيولوجية يُضعف بوضوح أثر الأوكسيتوسين في الرحم أو الغدة اللبنية، ويضيف ملخص خصائص مستحضر آخر لدى المديرية أن تنبيه المستقبلات الأدرينالية من نوع بيتا قد يقلّل آثار الأوكسيتوسين في الرحم والغدة اللبنية.\n\n## الاستعمالات البيطرية\n\nيذكر دليل MSD البيطري أن الأوكسيتوسين قد يُعطى في الحيوانات الصغيرة لتحفيز الترابط والسلوك الأمومي في الفترة التي تلي الولادة مباشرة. يذكر دليل MSD البيطري، في فصل إدارة تناسل الخنازير، أن العلاج الدوائي لعسر الولادة غير الانسدادي يمكن أن يشمل الأوكسيتوسين بوصفه عاملاً محرّضاً لانقباض الرحم. يشير فصل الحمل المطوّل لدى الأبقار والأغنام من دليل MSD البيطري إلى أن إعطاء الأوكسيتوسين قد يشجّع أوبة الرحم بعد إخراج الجنين. درست تجربة سريرية منشورة في مجلة Journal of Veterinary Medical Science عام 2019 أثر علاجين محرّضين لانقباض الرحم، هما الأوكسيتوسين والبروستاغلاندين F2α، في أوبة الرحم والتهاب بطانة الرحم بعد الولادة والأداء التناسلي. خلصت تجربة مجلة Journal of Veterinary Medical Science لعام 2019 إلى أن العلاج بالأوكسيتوسين أو بالبروستاغلاندين F2α خلال الأسبوع الأول بعد الولادة لم يغيّر تغييراً معنوياً معدل أوبة الرحم ولا انتشار التهاب بطانة الرحم، ولم يحسّن الأداء التناسلي الإجمالي مقارنة بحيوانات ضابطة غير معالجة.\n\n## السلامة\n\nتذكر مراجعة مجلة Animals لعام 2023 أن إعطاء الأوكسيتوسين من خارج الجسم ثبت أن له آثاراً ضارة بالجنين، كالاختناق وتلوّن الجنين بالعقي وتمزّق الحبل السري، إلى جانب زيادة حالات عسر الولادة لدى الإناث. ينبّه ملخص خصائص مستحضر من الأوكسيتوسين لدى مديرية الأدوية البيطرية في المملكة المتحدة (VMD) إلى أن استعمال المحاكيات الودية أو غيرها من مضيّقات الأوعية مع الأوكسيتوسين قد يؤدي إلى ارتفاع ضغط الدم بعد الولادة.\n\n## الوضع التنظيمي\n\nيذكر تقرير تقييم عام صادر في أيرلندا وتستضيفه مديرية الأدوية البيطرية في المملكة المتحدة (VMD) أن المادة الفعالة في المستحضر الذي يقيّمه هي الأوكسيتوسين، وأنها مادة راسخة موصوفة في دستور الأدوية الأوروبي.","oxytocin",null,[],[13,19,23,30,37,40,43,46,49,52,55],{"source":14,"licence":15,"source_url":16,"harvested_by":17,"retrieved_at":18},"FDA Green Book","US public domain","https:\u002F\u002Fanimaldrugsatfda.fda.gov\u002Fadafda\u002Fapp\u002Fsearch\u002Fpublic\u002FingredientsInformationExcel\u002FSection2ActiveIngredients","load-reference-corpus.cjs","2026-09-07",{"source":20,"licence":21,"source_url":22,"harvested_by":17,"retrieved_at":18},"UK VMD PID","OGL v3.0","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002Fproductinformationdatabase\u002Fdownloads\u002Fvmd_productinformationdatabase.xlsx",{"claims":24,"source":25,"licence":26,"source_url":27,"harvested_by":28,"retrieved_at":29},"Arabic name (heading)","bAItari term layer and label review (model-written, reviewer-confirmed)","original Arabic name","https:\u002F\u002Fbaitari.vet\u002Fdrugs\u002Foxytocin","apply-label-arabic.cjs label-core-2026-10-23","2026-10-23",{"claims":31,"source":32,"licence":33,"source_url":34,"harvested_by":35,"retrieved_at":36},"Arabic article (body)","MSD Veterinary Manual, Overview of Systemic Pharmacotherapeutics of the Reproductive System in Animals","facts cited; the Arabic article is original text","https:\u002F\u002Fwww.msdvetmanual.com\u002Fpharmacology\u002Fsystemic-pharmacotherapeutics-of-the-reproductive-system\u002Foverview-of-systemic-pharmacotherapeutics-of-the-reproductive-system","apply-chain-articles.cjs","2026-11-04",{"claims":31,"source":38,"licence":33,"source_url":39,"harvested_by":35,"retrieved_at":36},"UK VMD, Summary of Product Characteristics: Oxytocin-S solution for injection (2024)","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002FProductInformationDatabase\u002Ffiles\u002FSPC_Documents\u002FSPC_138196.PDF",{"claims":31,"source":41,"licence":33,"source_url":42,"harvested_by":35,"retrieved_at":36},"UK VMD, Summary of Product Characteristics: Oxytobel solution for injection (2019)","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002FProductInformationDatabase\u002Ffiles\u002FSPC_Documents\u002FSPC_672585.PDF",{"claims":31,"source":44,"licence":33,"source_url":45,"harvested_by":35,"retrieved_at":36},"HPRA public assessment report (hosted by UK VMD): Oxytobel 10 IU\u002Fml solution for injection","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002FProductInformationDatabase\u002Ffiles\u002FUKPAR_Documents\u002FUKPAR_1995206.PDF",{"claims":31,"source":47,"licence":33,"source_url":48,"harvested_by":35,"retrieved_at":36},"Animals (Basel) 2023, Clinical Experiences and Mechanism of Action with the Use of Oxytocin Injection at Parturition in Domestic Animals","https:\u002F\u002Fpmc.ncbi.nlm.nih.gov\u002Farticles\u002FPMC9952595\u002F",{"claims":31,"source":50,"licence":33,"source_url":51,"harvested_by":35,"retrieved_at":36},"MSD Veterinary Manual, Breeding Management of Pigs","https:\u002F\u002Fwww.msdvetmanual.com\u002Fmanagement-and-nutrition\u002Fmanagement-of-reproduction-pigs\u002Fbreeding-management-of-pigs",{"claims":31,"source":53,"licence":33,"source_url":54,"harvested_by":35,"retrieved_at":36},"MSD Veterinary Manual, Overview of Prolonged Gestation in Cattle and Sheep","https:\u002F\u002Fwww.msdvetmanual.com\u002Freproductive-system\u002Fprolonged-gestation-in-cattle-and-sheep\u002Foverview-of-prolonged-gestation-in-cattle-and-sheep",{"claims":31,"source":56,"licence":33,"source_url":57,"harvested_by":35,"retrieved_at":36},"J Vet Med Sci 2019, The impact of ecbolic therapy in the early postpartum period on uterine involution and reproductive health in dairy cows","https:\u002F\u002Fpmc.ncbi.nlm.nih.gov\u002Farticles\u002FPMC6451915\u002F",[59,66,72,75,80,83,85,89,92,98,101,103,106,109,113,117,119,123,126,130,133,137,141,143,146,149],{"id":60,"dose_text":61,"species":62,"administration_route":63,"limitation":64,"source_label":65},18645,"Administer 1.5 to 2.5 milliliter (30 to 50 U.S.P. units) Oxytocin injection intravenously, intramuscularly, or subcutaneously under aseptic conditions as indicated. The dosage is recommended and may be repeated as conditions require.","Swine (sows)","Subcutaneous, Intramuscular, Intravenous","Federal law restricts this drug to use by or on the order of a licensed veterinarian.","Vetocin Injection",{"id":67,"dose_text":68,"species":62,"administration_route":69,"limitation":70,"source_label":71},18646,"1.5 to 2.5 milliliter (30 to 50 U.S.P. units) Oxytocin injection. Administer drug intravenously, intramuscularly, or subcutaneously under aseptic conditions as indicated. The dosage may be repeated as conditions require.","Intramuscular, Intravenous, Subcutaneous","Do not use in dystocia due to abnormal presentation of fetus until correction is accomplished. For prepartum usage full relaxation of the cervix should be accomplished either naturally or by administration of estrogen prior to oxytocin therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.","Oxytocin Injection",{"id":73,"dose_text":74,"species":62,"administration_route":63,"limitation":64,"source_label":65},18647,"Administer 0.25 to 1.0 milliliter (5 to 20 U.S.P. units) Oxytocin injection. Intravenous administration is desirable. The dosage is recommended and may be repeated as conditions require.",{"id":76,"dose_text":77,"species":62,"administration_route":78,"limitation":70,"source_label":79},18648,"0.25 to 1.0 milliliter (5 to 20 U.S.P. units) Oxytocin injection administered intravenously. The dosage may be repeated as conditions require.","Intravenous, Intramuscular, Subcutaneous","Oxytocin Injectable",{"id":81,"dose_text":61,"species":82,"administration_route":63,"limitation":64,"source_label":65},18649,"Sheep (ewes)",{"id":84,"dose_text":68,"species":82,"administration_route":69,"limitation":70,"source_label":71},18650,{"id":86,"dose_text":87,"species":88,"administration_route":63,"limitation":64,"source_label":65},18651,"Administer 5.0 milliliter (100 U.S.P. units) Oxytocin injection intravenously, intramuscularly, or subcutaneously under aseptic conditions as indicated. The dosage is recommended and may be repeated as conditions require.","Horses",{"id":90,"dose_text":91,"species":88,"administration_route":69,"limitation":70,"source_label":71},18652,"5.0 milliliter (100 U.S.P. units) Oxytocin injection. Administer drug intravenously, intramuscularly, or subcutaneously under aseptic conditions as indicated. The dosage may be repeated as conditions require.",{"id":93,"dose_text":94,"species":88,"administration_route":95,"limitation":96,"source_label":97},18653,"100 U.S.P. Units (5 mL)","Subcutaneous, Intravenous, Intramuscular","Do not use in dystocia due to\nabnormal presentation of fetus until correction is\naccomplished.","Oxytocin (Label Under Distributors)",{"id":99,"dose_text":87,"species":100,"administration_route":63,"limitation":64,"source_label":65},18654,"Cattle (cows)",{"id":102,"dose_text":91,"species":100,"administration_route":69,"limitation":70,"source_label":71},18655,{"id":104,"dose_text":105,"species":100,"administration_route":63,"limitation":64,"source_label":65},18656,"Administer 0.5 to 1.0 milliliter (10 to 20 U.S.P. units) Oxytocin injection. Intravenous administration is desirable. The dosage is recommended and may be repeated as conditions require.",{"id":107,"dose_text":108,"species":100,"administration_route":78,"limitation":70,"source_label":79},18657,"0.5 to 1.0 milliliter (10 to 20 U.S.P. units) Oxytocin injection administered intravenously. The dosage may be repeated as conditions require.",{"id":110,"dose_text":105,"species":111,"administration_route":112,"limitation":70,"source_label":71},18658,"Cattle (sows)","Intramuscular, Subcutaneous, Intravenous",{"id":114,"dose_text":115,"species":116,"administration_route":112,"limitation":70,"source_label":71},18659,"Administer 1.5 to 2.5 milliliter (30 to 50 U.S.P. units) Oxytocin injection intravenously, intramuscularly, or subcutaneously under aseptic conditions. The dosage is recommended and may be repeated as conditions require.","Swine",{"id":118,"dose_text":74,"species":116,"administration_route":112,"limitation":70,"source_label":71},18660,{"id":120,"dose_text":121,"species":122,"administration_route":63,"limitation":64,"source_label":65},18661,"Administer 0.25 to 1.5 milliliter (5 to 30 U.S.P. units) Oxytocin injection intravenously, intramuscularly, or subcutaneously under aseptic conditions as indicated. The dosage is recommended and may be repeated as conditions require.","Dogs",{"id":124,"dose_text":125,"species":122,"administration_route":69,"limitation":70,"source_label":71},18662,"0.25 to 1.5 milliliter (5 to 30 U.S.P. units) Oxytocin injection. Administer drug intravenously, intramuscularly, or subcutaneously under aseptic conditions as indicated. The dosage may be repeated as conditions require.",{"id":127,"dose_text":128,"species":129,"administration_route":63,"limitation":64,"source_label":65},18663,"Administer 0.25 to 0.5 milliliters (5 to 10 U.S.P. units) Oxytocin injection intravenously, intramuscularly, or subcutaneously under aseptic conditions as indicated. The dosage is recommended and may be repeated as conditions require.","Cats",{"id":131,"dose_text":132,"species":129,"administration_route":69,"limitation":70,"source_label":71},18664,"0.25 to 0.5 milliliter (5 to 10 U.S.P. units) Oxytocin injection. Administer drug intravenously, intramuscularly, or subcutaneously under aseptic conditions as indicated. The dosage may be repeated as conditions require.",{"id":134,"dose_text":135,"species":136,"administration_route":95,"limitation":96,"source_label":97},18665,"30 to 50 U.S.P. Units (1 1\u002F2 to 2 1\u002F2 mL)","Ewes",{"id":138,"dose_text":139,"species":140,"administration_route":95,"limitation":96,"source_label":97},18666,"10-20 U.S.P. Units (1\u002F2 to 1 mL)","Cows",{"id":142,"dose_text":94,"species":140,"administration_route":95,"limitation":96,"source_label":97},18667,{"id":144,"dose_text":135,"species":145,"administration_route":95,"limitation":96,"source_label":97},18668,"Sows",{"id":147,"dose_text":148,"species":145,"administration_route":95,"limitation":96,"source_label":97},18669,"5-20 U.S.P. Units (1\u002F4 to 1 mL)",{"id":150,"dose_text":151,"species":10,"administration_route":152,"limitation":10,"source_label":153},18670,"DOSAGE AND ADMINISTRATION:\nObstetrical Use: Inject aseptically by the intravenous, intramuscular or subcutaneous route as follows:\nEwes, Sows:\n1.5 to 2.5mL......................30 to 50 USP Units\nCows, Horses:\n5.0mL...............................100 USP Units\nThese dosages are recommended, and may be repeated as indicated.\nMilk Let-down:\nInject aseptically by the intravenous, intramuscular or subcutaneous route\nCows:\n0.5 to 1.0mL.....................10 to 20 USP Units\nSows:\n0.25 to 1.0mL....................5 to 20 USP Units\nThese dosages are recommended and may be repeated as necessary.\nNote: Oxytocin will not induce milk let-down unless the udder is in proper physiological state.","INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS","FDA application 200-328",[155,159,161,163,165,168,170,172,174,176,178,180,182,184,186,188,190,192,194,196,198,200,202,204,207,209,211,213,216,218,220,222,224,226,228],{"id":156,"strength_text":157,"dosage_form":158,"proprietary_name":71,"species":62,"source_label":71},16363,"Each milliliter of oxytocin injection contains 20 U.S.P. units of oxytocin.","Liquid (Solution)",{"id":160,"strength_text":157,"dosage_form":158,"proprietary_name":71,"species":82,"source_label":71},16364,{"id":162,"strength_text":157,"dosage_form":158,"proprietary_name":71,"species":88,"source_label":71},16365,{"id":164,"strength_text":157,"dosage_form":158,"proprietary_name":71,"species":100,"source_label":71},16366,{"id":166,"strength_text":157,"dosage_form":167,"proprietary_name":71,"species":111,"source_label":71},16367,"Liquid",{"id":169,"strength_text":157,"dosage_form":167,"proprietary_name":71,"species":82,"source_label":71},16368,{"id":171,"strength_text":157,"dosage_form":167,"proprietary_name":71,"species":116,"source_label":71},16369,{"id":173,"strength_text":157,"dosage_form":167,"proprietary_name":71,"species":122,"source_label":71},16370,{"id":175,"strength_text":157,"dosage_form":167,"proprietary_name":71,"species":100,"source_label":71},16371,{"id":177,"strength_text":157,"dosage_form":167,"proprietary_name":71,"species":129,"source_label":71},16372,{"id":179,"strength_text":157,"dosage_form":167,"proprietary_name":71,"species":88,"source_label":71},16373,{"id":181,"strength_text":157,"dosage_form":167,"proprietary_name":65,"species":129,"source_label":65},16374,{"id":183,"strength_text":157,"dosage_form":167,"proprietary_name":65,"species":82,"source_label":65},16375,{"id":185,"strength_text":157,"dosage_form":167,"proprietary_name":65,"species":62,"source_label":65},16376,{"id":187,"strength_text":157,"dosage_form":167,"proprietary_name":65,"species":100,"source_label":65},16377,{"id":189,"strength_text":157,"dosage_form":167,"proprietary_name":65,"species":88,"source_label":65},16378,{"id":191,"strength_text":157,"dosage_form":167,"proprietary_name":65,"species":122,"source_label":65},16379,{"id":193,"strength_text":157,"dosage_form":167,"proprietary_name":79,"species":129,"source_label":79},16380,{"id":195,"strength_text":157,"dosage_form":167,"proprietary_name":79,"species":122,"source_label":79},16381,{"id":197,"strength_text":157,"dosage_form":167,"proprietary_name":79,"species":82,"source_label":79},16382,{"id":199,"strength_text":157,"dosage_form":167,"proprietary_name":79,"species":62,"source_label":79},16383,{"id":201,"strength_text":157,"dosage_form":167,"proprietary_name":79,"species":100,"source_label":79},16384,{"id":203,"strength_text":157,"dosage_form":167,"proprietary_name":79,"species":88,"source_label":79},16385,{"id":205,"strength_text":206,"dosage_form":167,"proprietary_name":97,"species":136,"source_label":97},16386,"Each mL Contains: Oxytocic Activity Equivalent to 20\nUSP Posterior Pituitary units with Sodium\nHydroxide\u002FAcetic Acid for pH adjustment.",{"id":208,"strength_text":206,"dosage_form":167,"proprietary_name":97,"species":88,"source_label":97},16387,{"id":210,"strength_text":206,"dosage_form":167,"proprietary_name":97,"species":140,"source_label":97},16388,{"id":212,"strength_text":206,"dosage_form":167,"proprietary_name":97,"species":145,"source_label":97},16389,{"id":214,"strength_text":157,"dosage_form":167,"proprietary_name":215,"species":129,"source_label":215},16390,"PVL Oxytocin Injectable",{"id":217,"strength_text":157,"dosage_form":167,"proprietary_name":215,"species":122,"source_label":215},16391,{"id":219,"strength_text":157,"dosage_form":167,"proprietary_name":215,"species":82,"source_label":215},16392,{"id":221,"strength_text":157,"dosage_form":167,"proprietary_name":215,"species":62,"source_label":215},16393,{"id":223,"strength_text":157,"dosage_form":167,"proprietary_name":215,"species":100,"source_label":215},16394,{"id":225,"strength_text":157,"dosage_form":167,"proprietary_name":215,"species":88,"source_label":215},16395,{"id":227,"strength_text":157,"dosage_form":167,"proprietary_name":71,"species":62,"source_label":71},16396,{"id":229,"strength_text":230,"dosage_form":10,"proprietary_name":10,"species":10,"source_label":153},16397,"20 [USP'U] \u002F 1 mL",[232,236,239,241,243,245,247,250,253,255,257,259,262,264,267,269,271,274,278],{"id":233,"kind":234,"statement":235,"species":62,"limitation":70,"source_label":71},27647,"indication","Obstetrical- Oxytocin may be used as a uterine contractor to precipitate and accelerate normal parturition and postpartum evacuation of uterine debris. In surgery it may be used postoperatively following cesarean section to facilitate involution and resistance to the large inflow of blood.",{"id":237,"kind":234,"statement":238,"species":62,"limitation":70,"source_label":71},27648,"Milk letdown- Oxytocin will contract smooth muscle cells of the mammary gland for milk letdown if the udder is in proper physiological state.",{"id":240,"kind":234,"statement":235,"species":82,"limitation":70,"source_label":71},27649,{"id":242,"kind":234,"statement":235,"species":88,"limitation":70,"source_label":71},27650,{"id":244,"kind":234,"statement":235,"species":100,"limitation":70,"source_label":71},27651,{"id":246,"kind":234,"statement":238,"species":100,"limitation":70,"source_label":71},27652,{"id":248,"kind":234,"statement":249,"species":111,"limitation":70,"source_label":71},27653,"Milk letdown. It will contract smooth muscle cells of the mammary gland for milk letdown if the udder is in proper physiological state.",{"id":251,"kind":234,"statement":252,"species":116,"limitation":70,"source_label":71},27654,"Obstetrical. Oxytocin may be used as a uterine contractor to precipitate and accelerate normal parturition and postpartum evacuation of uterine debris. In surgery it may be used postoperatively following cesarean section to facilitate involution and resistance to the large inflow of blood.",{"id":254,"kind":234,"statement":249,"species":116,"limitation":70,"source_label":71},27655,{"id":256,"kind":234,"statement":252,"species":122,"limitation":70,"source_label":71},27656,{"id":258,"kind":234,"statement":252,"species":129,"limitation":70,"source_label":71},27657,{"id":260,"kind":234,"statement":261,"species":136,"limitation":96,"source_label":97},27658,"Oxytocin may be used as a uterine contractor to precipitate and accelerate normal parturition and postpartum evacuation of uterine debris. In surgery it may be used postoperatively following cesarean section to facilitate involution and resistance to the large inflow of blood.",{"id":263,"kind":234,"statement":261,"species":140,"limitation":96,"source_label":97},27659,{"id":265,"kind":234,"statement":266,"species":140,"limitation":96,"source_label":97},27660,"Oxytocin may be used as to contract smooth muscle cells of the mammary gland for milk letdown if the udder is in proper physiological state.",{"id":268,"kind":234,"statement":261,"species":145,"limitation":96,"source_label":97},27661,{"id":270,"kind":234,"statement":266,"species":145,"limitation":96,"source_label":97},27662,{"id":272,"kind":234,"statement":273,"species":10,"limitation":10,"source_label":153},27663,"INDICATIONS: Because of the specific action of oxytocin upon the uterine musculature, it is recommended as an aid in the management of the following conditions:\n1. To precipitate labor.\n2. To accelerate normal parturition.\n3. Postpartum evacuation of uterine debris.\n4. Postoperative contraction of the uterus following a cesarean section and control of uterine hemorrhage.\nOxytocin will contract the smooth muscle cells of the mammary gland to induce milk let-down if the udder is in a proper physiological state.",{"id":275,"kind":276,"statement":277,"species":10,"limitation":10,"source_label":153},27664,"contraindication","CONTRAINDICATION:\nDo not use in dystocia due to abnormal presentation of the fetus until correction is accomplished.",{"id":279,"kind":280,"statement":281,"species":10,"limitation":10,"source_label":153},27665,"adverse_reaction","To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Bimeda, Inc. at 1-888-524-6332. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at www.fda.gov\u002Freportanimalae.",[],[],[285],{"id":286,"documentId":287,"slug":288,"title":289,"heading":290},281,"e3wga7pef9kwczpw6gfgmt3j","metritis","Metritis","التهاب الرحم",[]]